Godfrey Phillips India Limited (GODFRYPHLP) — Board Meeting(3 announcements)

The Board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, confirming an unmodified auditor's opinion and declaring a final dividend of ₹33 per share (1650% of face value) subject to shareholder approval at the upcoming AGM, with payment due within 30 days of the meeting. The results include revenue of ₹348,554 lakhs for the quarter and ₹908,246 lakhs for the year, reflecting strong operational performance and profitability. The company also announced a 2:1 bonus share issue capitalizing General Reserves, enhancing shareholder value through increased holdings without cash outflow. The financial statements comply with SEBI regulations and Ind AS 33, and are available on the company's website and stock exchange platforms.

Godfrey Phillips India announced on May 15, 2026, that its board approved a three-year distribution agreement with Aspeya India Private Limited to market nicotine replacement therapy products through existing trade channels. The deal leverages the company's distribution network to expand its product portfolio and revenue streams. The agreement is part of the promoter group's pharmaceutical distribution network and will be conducted at arm's length.

Godfrey Phillips India announced the appointment of Rajesh Menon as Chief Commercial and Operations Officer effective September 1, 2026, following board approval at its May 15, 2026 meeting. The move strengthens supply chain and operations leadership with over 30 years of industry experience.